Loading…
Insecticides (India) (INSECTICID)₹541.30−2.28%Pesticides & Agrochemicals
In the Jun 2026 quarter (consolidated), Insecticides (India) reported sales of ₹611 Cr, down 11.4% from Jun 2025, and net profit of ₹44.13 Cr, down 24.1% year on year. For the year to Mar 2026, sales were ₹2,137 Cr and net profit ₹139 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 695 | 357 | 272 | 656 | 626 | 358 | 358 | 690 | 636 | 384 | 425 | 611 |
| Expenses | 614 | 332 | 264 | 585 | 538 | 327 | 330 | 607 | 548 | 358 | 401 | 544 |
| Operating Profit | 81.86 | 25.96 | 8.98 | 71.94 | 89.95 | 30.96 | 27.98 | 84.92 | 88.83 | 26.99 | 24.95 | 67.94 |
| OPM % | 11.9% | 7.0% | 3.3% | 10.9% | 13.9% | 8.9% | 8.0% | 11.9% | 14.0% | 7.0% | 6.0% | 10.9% |
| Other Income | 0.00 | 1.01 | 5.01 | 3.01 | 2.01 | 0.00 | 3.01 | 4.01 | 3.01 | 1.01 | 5.01 | 6.02 |
| Interest | 3.01 | 3.01 | 2.01 | 2.01 | 2.01 | 1.01 | 2.01 | 4.01 | 4.01 | 5.01 | 4.01 | 5.01 |
| Depreciation | 7.01 | 7.01 | 8.01 | 7.01 | 7.01 | 8.02 | 7.02 | 7.01 | 9.01 | 9.02 | 9.02 | 10.02 |
| Profit before tax | 72.15 | 17.03 | 4.01 | 66.06 | 82.06 | 22.03 | 22.03 | 77.04 | 79.14 | 14.02 | 16.01 | 59.07 |
| Tax % | 26.0% | 28.0% | −106.0% | 25.0% | 25.0% | 22.1% | 37.1% | 25.0% | 25.0% | 27.0% | 27.0% | 25.1% |
| Net Profit | 53.14 | 12.04 | 8.02 | 49.16 | 61.19 | 17.04 | 14.05 | 58.15 | 59.16 | 10.03 | 12.03 | 44.13 |
| EPS (Rs) | 18.03 | 4.17 | 2.63 | 16.72 | 21.20 | 5.99 | 4.79 | 20.03 | 20.38 | 3.62 | 4.04 | 15.13 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 904 | 993 | 1,071 | 1,193 | 1,360 | 1,418 | 1,502 | 1,797 | 1,963 | 1,995 | 2,137 | 2,057 |
| Expenses | 814 | 883 | 925 | 1,005 | 1,206 | 1,268 | 1,332 | 1,678 | 1,804 | 1,779 | 1,914 | 1,851 |
| Operating Profit | 91.92 | 112 | 148 | 188 | 156 | 153 | 171 | 122 | 162 | 221 | 227 | 209 |
| OPM % | 9.9% | 10.9% | 13.9% | 15.9% | 10.9% | 10.9% | 10.9% | 7.0% | 7.9% | 10.9% | 10.9% | 10.2% |
| Other Income | 0.00 | 7.02 | 3.01 | 1.01 | 3.01 | −2.01 | 3.01 | 1.01 | 10.03 | 8.03 | 12.03 | 15.05 |
| Interest | 26.06 | 20.05 | 16.03 | 15.04 | 24.03 | 7.01 | 7.02 | 13.02 | 11.03 | 7.01 | 17.03 | 18.04 |
| Depreciation | 16.03 | 16.04 | 17.02 | 20.05 | 24.04 | 25.04 | 26.07 | 26.04 | 29.04 | 29.06 | 36.06 | 37.07 |
| Profit before tax | 50.10 | 82.15 | 118 | 153 | 111 | 120 | 141 | 84.17 | 132 | 193 | 187 | 168 |
| Tax % | 21.0% | 27.0% | 29.0% | 20.0% | 22.0% | 21.0% | 24.0% | 25.0% | 23.1% | 26.1% | 25.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −8.01 | −1.01 | 0.00 | 1.01 | 0.00 | 1.01 | — |
| Net Profit | 40.13 | 60.14 | 84.28 | 123 | 87.20 | 94.30 | 107 | 63.13 | 102 | 143 | 139 | 125 |
| EPS (Rs) | 12.82 | 19.34 | 27.28 | 39.76 | 28.13 | 30.40 | 36.43 | 21.45 | 34.60 | 48.96 | 48.10 | 43.17 |
| Dividend payout % | 10.0% | 7.0% | 5.0% | 3.0% | 10.0% | 4.0% | 6.0% | 14.0% | 9.0% | 4.0% | 4.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13.03 | 21.07 | 21.07 | 21.08 | 21.07 | 21.05 | 21.08 | 20.07 | 30.12 | 30.08 | 29.09 | 29.08 |
| Reserves | 278 | 387 | 443 | 526 | 640 | 710 | 799 | 849 | 888 | 980 | 1,055 | 1,189 |
| Borrowings | 323 | 207 | 238 | 114 | 306 | 191 | 100 | 54.15 | 164 | 87.26 | 105 | 158 |
| Other Liabilities | 309 | 323 | 278 | 340 | 389 | 374 | 507 | 475 | 618 | 623 | 712 | 626 |
| Total Liabilities | 922 | 937 | 979 | 1,001 | 1,357 | 1,295 | 1,428 | 1,397 | 1,699 | 1,720 | 1,900 | 2,002 |
| Fixed Assets | 211 | 199 | 186 | 233 | 241 | 240 | 240 | 254 | 264 | 287 | 283 | 371 |
| CWIP | 38.01 | 51.07 | 58.02 | 17.01 | 19.01 | 39.05 | 59.02 | 91.08 | 123 | 142 | 161 | 130 |
| Investments | 3.01 | 3.01 | 11.03 | 17.06 | 12.03 | 12.03 | 14.03 | 16.06 | 17.06 | 23.06 | 29.08 | 29.09 |
| Other Assets | 671 | 685 | 726 | 736 | 1,084 | 1,004 | 1,117 | 1,038 | 1,296 | 1,268 | 1,427 | 1,473 |
| Inventories | 390 | 350 | 425 | 406 | 704 | 518 | 660 | 629 | 860 | 805 | 884 | 779 |
| Trade receivables | 167 | 208 | 213 | 236 | 245 | 321 | 256 | 290 | 297 | 298 | 386 | 488 |
| Cash & equivalents | 9.02 | 12.04 | 9.02 | 20.06 | 9.03 | 74.19 | 83.29 | 36.11 | 20.07 | 61.16 | 57.13 | 87.20 |
| Total Assets | 922 | 937 | 979 | 1,001 | 1,357 | 1,295 | 1,428 | 1,397 | 1,699 | 1,720 | 1,900 | 2,002 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −6.01 | 86.03 | 4.01 | 182 | −133 | 242 | 155 | 135 | −11.01 | 187 | 92.99 | 100 |
| Cash from investing activity | −34.03 | −19.01 | −14.01 | −26.01 | −49.04 | −24.01 | −113 | 9.01 | −86.07 | −46.04 | −38.01 | −85.99 |
| Cash from financing activity | 35.94 | −63.96 | 8.98 | −143 | 172 | −159 | −104 | −115 | 79.91 | −97.80 | −60.92 | 17.97 |
| Net cash flow | −4.01 | 3.99 | 0.00 | 12.99 | −11.01 | 59.04 | −61.04 | 30.02 | −16.99 | 42.02 | −4.99 | 30.98 |
| Capex | 35.04 | 20.02 | 14.02 | 28.03 | 38.08 | 29.04 | 48.05 | 67.10 | 87.12 | 49.10 | 37.07 | 95.18 |
| Free cash flow | −40.11 | 67.16 | −10.03 | 154 | −171 | 214 | 108 | 68.25 | −97.34 | 143 | 59.20 | 8.03 |
| CFO / OP % | 1.0% | 108.0% | 19.0% | 140.0% | −54.0% | 175.0% | 120.0% | 103.0% | 16.0% | 123.9% | 61.0% | 69.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 69 | 85 | 79 | 81 | 76 | 87 | 66 | 71 | 61 | 56 | 71 | 84 |
| Inventory days | 220 | 190 | 232 | 214 | 355 | 202 | 248 | 228 | 247 | 221 | 268 | 215 |
| Days payable | 119 | 115 | 109 | 129 | 142 | 97 | 137 | 118 | 129 | 116 | 155 | 122 |
| Cash conversion cycle | 169 | 158 | 200 | 165 | 288 | 191 | 176 | 180 | 177 | 160 | 184 | 176 |
| Working capital days | 40 | 75 | 80 | 93 | 116 | 98 | 108 | 111 | 92 | 97 | 106 | 105 |
| ROCE % | — | 12.0% | 16.0% | 20.0% | 21.0% | 14.0% | 15.0% | 16.0% | 10.0% | 13.0% | 17.0% | 16.0% |
For the Jun 2026 quarter, Insecticides (India) reported sales of ₹611 Cr, down 11.4% year on year and net profit of ₹44.13 Cr, down 24.1% year on year. The operating margin was 10.9%.
Insecticides (India)'s sales for the year to Mar 2026 were ₹2,137 Cr; over the last twelve months they were ₹2,057 Cr.
Net profit for the year to Mar 2026 was ₹139 Cr, and ₹125 Cr over the last twelve months. Earnings per share over the same trailing period were ₹43.17.
Insecticides (India) reported borrowings of ₹158 Cr at Mar 2026, against cash and equivalents of ₹87.20 Cr.
Cash from operations was ₹100 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹8.03 Cr.